Clinic
Med 360 Urgent Care, LLC
Med 360 Urgent Care, LLC was paid $1.52M by Medicaid between Nov 2019 and Mar 2024, across 42 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 25% of everything it billed.
33Billing provider infoMED 360 URGENT CARE, LLC
JASPER, AL 35501
JASPER, AL 35501
33aNPI1871044677assigned 10/18/2016
33bProvider typeUrgent Care Clinic/Center
28Total paid$1.52M
24GClaims57,751
24DCodes billed42
24AFirst – last monthNov 2019 – Mar 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Alabama
Rank by total paid#3 of 59
Median peer was paid$77K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 1,218 | $7K | |
| 2020 | 4,026 | $73K | |
| 2021 | 13,048 | $329K | |
| 2022 | 21,353 | $650K | |
| 2023 | 16,055 | $405K | |
| 2024incomplete | 2,051 | $55K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 25% | 2,100 | 1,967 | $381K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 18% | 1,846 | 1,635 | $280K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.7% | 3,140 | 2,558 | $118K |
| 87634 | 5.6% | 2,092 | 1,931 | $85K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5.5% | 2,028 | 1,871 | $83K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.3% | 1,726 | 1,520 | $81K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.8% | 1,698 | 1,249 | $73K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.6% | 2,440 | 2,240 | $55K |
| 87581 | 3.5% | 2,370 | 2,160 | $53K | |
| 87486 | 3.1% | 2,144 | 1,936 | $47K | |
| 87640 | 3.0% | 2,482 | 2,279 | $46K | |
| 87541 | 2.9% | 1,973 | 1,776 | $43K |
30 more codes
| 87498 | 2.5% | 2,137 | $38K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 3,681 | $28K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 644 | $23K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 826 | $18K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.1% | 1,149 | $16K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 166 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,042 | $12K |
| 87641 | <1% | 717 | $11K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,325 | $9K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 542 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 128 | $2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 21 | $682.29 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $518.40 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,052 | $431.64 |
| 80051 | <1% | 25 | $168.00 | |
| 87807 | <1% | 32 | $99.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 581 | $73.74 |
| 3080F | 0% | 13 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,126 | $0.00 |
| 3074F | 0% | 2,186 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 1,599 | $0.00 |
| 36416 | 0% | 876 | $0.00 | |
| 3079F | 0% | 67 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 14 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,609 | $0.00 |
| 3078F | 0% | 1,976 | $0.00 | |
| 99072 | 0% | 1,801 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 3,879 | $0.00 |
| 87999 | 0% | 469 | $0.00 | |
| 3077F | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAQUIB, FAROUK (OWNER/PHYSICIAN)
| Provider | Location | Paid |
|---|---|---|
| Farouk A. Raquib, M.D., P.C. | Winfield, AL | $6.24M |
| Med 360 Urgent Care Northport LLC | Northport, AL | $785K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.